Muse+TriposScore: a ligand-based de novo design approach
نویسندگان
چکیده
Successful drug discovery often requires optimization against a set of biological and physical properties. We describe our work on multi-parameter approaches to ligand-based de novo design and studies that demonstrate its ability to successfully generate lead hops or scaffold hops between known classes of ligands for some example receptors. We describe a multi-criteria scoring function incorporating molecular shape similarity, molecular fingerprint similarity, and a number of popular “Lipinski-like” molecular properties. Muse is based on an evolutionary algorithm that operates on an initial population of structures to invent new structures with improved scores. Muse is unique in that it has the ability to work with any user-defined scoring function that provides results in the form of a numerical evaluation of designed structures. Several retrospective studies on various targets demonstrate the ability of the above mentioned approach to generate novel ideas that are not only appealing to design scientists but are also validated by comparison to compounds known to demonstrate activity at the desired biological target. Specific examples where this approach has generated either significant modifications of existing molecular frameworks or structurally new molecular templates relative to design starting points (i.e., lead hopping) will be provided.
منابع مشابه
Multi-parameter scoring functions for ligand- and structure-based de novo design
Successful drug discovery often requires optimization against a set of biological and physical properties. We describe de novo design studies that demonstrate successful scaffold hops between known classes of ligands for p38 MAP kinases using ligand-based and structurebased multi-parameter scoring functions coupled to the molecular invention engine Muse. The ligand-based scoring function includ...
متن کاملAn Automated Ligand Evolution System using Bayesian Optimization Algorithm∗
Ligand docking checks whether a drug chemical called ligand matches the target receptor protein of human organ or not. Docking by computer simulation is becoming popular in drug design process to reduce cost and time of the chemical experiments. This paper presents a novel approach generating optimal ligand structures from scratch based on de novo ligand design approach employing Bayesian optim...
متن کاملNew Approach to Peptide Ligand Design Based on Atom-by- atom de novo Design
De novo ligand design is a key developing technology for the computer-aided design of enzyme inhibitors. By this method, one can design a number of novel inhibitor candidates based on the 3D structure of the target enzyme [1-6]. There are two different ways to design ligands de novo. One is so called atom by atom, and the other is fragment-based. Nonpeptide inhibitors are more desirable than pe...
متن کاملEvolutionary algorithms and de novo peptide design
Automated de novo design of bioactive molecules is one of the aspired goals in computational chemistry. Despite significant progresses in computational approaches for ligand design and efficient evaluation of binding energy, novel procedures for ligand design are required. Evolutionary computation provides a new approach to this design issue. This paper proposes a framework for evolving ligands...
متن کاملDOGS: Reaction-Driven de novo Design of Bioactive Compounds
We present a computational method for the reaction-based de novo design of drug-like molecules. The software DOGS (Design of Genuine Structures) features a ligand-based strategy for automated 'in silico' assembly of potentially novel bioactive compounds. The quality of the designed compounds is assessed by a graph kernel method measuring their similarity to known bioactive reference ligands in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 3 شماره
صفحات -
تاریخ انتشار 2011